We are live on ! Find out more
BGM

Burkehill Global Management Portfolio holdings

AUM $2.02B
1-Year Est. Return 85.32%
This Fund
S&P 500
This Quarter Est. Return
+11.94%
1 Year Est. Return
+85.32%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.02B
AUM Growth
+$498M
Cap. Flow
+$466M
Cap. Flow %
23.08%
Top 10 Hldgs %
41.93%
Holding
218
New
58
Increased
7
Reduced
12
Closed
36

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$147M
2
DLR icon
Digital Realty Trust
DLR
+$128M
3
FANG icon
Diamondback Energy
FANG
+$114M
4
NRG icon
NRG Energy
NRG
+$70.8M
5
SNDK
Sandisk
SNDK
+$70.6M

Top Sells

Rank Stock Value
1
ITT icon
ITT
ITT
+$60.7M
2
SOFI icon
SoFi Technologies
SOFI
+$52.4M
3
NDAQ icon
Nasdaq
NDAQ
+$48.6M
4
EL icon
Estee Lauder
EL
+$47.1M
5
ROL icon
Rollins
ROL
+$43.5M

Sector Composition

Rank Sector Weight
1 Healthcare 22.71%
2 Technology 19.4%
3 Industrials 18.69%
4 Energy 10.65%
5 Real Estate 8.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DNTH icon
76
Dianthus Therapeutics
DNTH
$5.68B
$4.2M 0.21%
+50,000
New +$2.9M
NP
77
Neptune Insurance Holdings
NP
$4.15B
$4.17M 0.21%
172,500
– –
ANDG
78
Andersen Group
ANDG
$4.84B
$4.08M 0.2%
150,000
– –
MLYS icon
79
Mineralys Therapeutics
MLYS
$2.35B
$4.06M 0.2%
150,000
– –
NTST
80
NETSTREIT Corp
NTST
$2.16B
$4.02M 0.2%
+213,515
New +$4.11M
WBI
81
WaterBridge Infrastructure LLC
WBI
$1.64B
$4.02M 0.2%
150,000
– –
SPXC icon
82
SPX Corp
SPXC
$11B
$4M 0.2%
20,000
-30,000
-60% -$6.45M
NAVN
83
Navan Inc
NAVN
$5.9B
$3.97M 0.2%
300,000
– –
DNLI icon
84
Denali Therapeutics
DNLI
$3.67B
$3.84M 0.19%
200,000
– –
CMPX icon
85
Compass Therapeutics
CMPX
$373M
$3.7M 0.18%
700,000
– –
ALMS
86
Alumis Inc
ALMS
$3.57B
$3.63M 0.18%
+165,000
New +$4.12M
CRNX icon
87
Crinetics Pharmaceuticals
CRNX
$8.86B
$3.63M 0.18%
+100,000
New +$4.47M
FLY
88
Firefly Aerospace
FLY
$3.23B
$3.56M 0.18%
125,000
– –
HPP
89
Hudson Pacific Properties
HPP
$834M
$3.38M 0.17%
571,428
– –
BETA
90
Beta Technologies Inc
BETA
$4.2B
$3.31M 0.16%
225,000
– –
WLTH
91
Wealthfront Corp
WLTH
$1.33B
$3.24M 0.16%
350,000
– –
IRON icon
92
Disc Medicine
IRON
$2.83B
$3.2M 0.16%
50,000
– –
PTRN
93
Pattern Group Inc
PTRN
$3.92B
$3.11M 0.15%
250,000
– –
AGRO icon
94
Adecoagro
AGRO
$1.53B
$3M 0.15%
200,000
– –
TTAM
95
Titan America SA
TTAM
$3.16B
$3M 0.15%
200,000
– –
CBC
96
Central Bancompany Inc
CBC
$7.68B
$2.99M 0.15%
125,000
– –
MBX
97
MBX Biosciences
MBX
$2.95B
$2.98M 0.15%
100,000
– –
BOBS
98
Bobs Discount Furniture
BOBS
$1.97B
$2.94M 0.15%
+250,000
New +$4.26M
PCVX icon
99
Vaxcyte
PCVX
$7.89B
$2.91M 0.14%
+50,000
New +$2.71M
GPCR icon
100
Structure Therapeutics
GPCR
$3.49B
$2.89M 0.14%
60,000
– –
2 3
4
5 6

Similar funds

AF
Alerus Financial Grand Forks, North Dakota $2.02B AUM 26.03% 1-Year Est. Return
NIM
NXG Investment Management Dallas, Texas $2.02B AUM 30.38% 1-Year Est. Return
C
Consulta London, United Kingdom $2.01B AUM 16.82% 1-Year Est. Return
LI
Leeward Investments Boston, Massachusetts $2.03B AUM 32.21% 1-Year Est. Return
LBC
Lowe Brockenbrough & Co Richmond, Virginia $2.01B AUM 22.05% 1-Year Est. Return
GIM
Generate Investment Management Auckland, New Zealand $2.03B AUM 26.86% 1-Year Est. Return
MYAM
Meiji Yasuda Asset Management Tokyo, Japan $2B AUM 22.52% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Burkehill Global Management's Q1 2026 Portfolio in Review

As of Q1 2026, Burkehill Global Management held 218 positions worth $2.02B, up 33% from $1.52B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Burkehill Global Management deployed $466M of net new capital in Q1 2026, opening 58 new positions and adding to 7 existing holdings. Its largest new stake was Eli Lilly: 145,000 shares worth $133M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 19% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Nebius Group N.V., an estimated $22.5M trimmed.

  • Burkehill Global Management's largest Q1 2026 buy was Eli Lilly: 145,000 shares worth $133M.
  • Burkehill Global Management added most to Medline Inc in Q1 2026, an estimated $43.4M increase.
  • Burkehill Global Management's biggest Q1 2026 reduction was Nebius Group N.V., cutting an estimated $22.5M.
  • Burkehill Global Management fully exited ITT in Q1 2026, selling an estimated $60.7M.
  • Burkehill Global Management's ten largest holdings make up 42% of its $2.02B portfolio in Q1 2026.
  • Burkehill Global Management opened 58 new positions and closed 36 in Q1 2026.
  • Burkehill Global Management's portfolio value rose 33% quarter-over-quarter to $2.02B.

Based on Burkehill Global Management's 13F filing for Q1 2026, filed 15 May 2026.